Literature DB >> 2371782

HIV-1 infection of normal human macrophage cultures: implication for silent infection.

A Valentin1, J Albert, E M Fenyö, B Asjö.   

Abstract

We have investigated the replicative capacity of 14 primary HIV-1 isolates in cultures of normal blood macrophages and PHA-stimulated peripheral blood mononuclear cells (PBMC). All viruses could infect normal macrophages as demonstrated by either reverse transcriptase (RT) activity, p24 antigen assay, or cocultivation with PBMC. One month after infection of macrophages virus could no longer be detected in the culture medium. The cells remained in this nonproductive state for another month. Virus could, however, be recovered by cocultivation with PHA-stimulated PBMC. Such macrophage-passaged virus induced pronounced cell killing with fragmentation and pyknosis and often replicated poorly in PBMC, in contrast to the original isolate. The results indicate that all primary HIV-1 isolates contain virus variants that can infect cells of the monocyte/macrophage lineage. Persistently infected, seemingly nonproducing cells, may serve as infectious reservoirs in the infected individual and spread infection to other susceptible cells over a long period of time. Moreover, the pronounced killing of PBMC by the macrophage-harbored virus may contribute to the deterioration of the immune system.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2371782     DOI: 10.1016/0042-6822(90)90551-2

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  13 in total

1.  Internalization of CD4 molecules in human T-cells demonstrated by immuno-electron microscopy.

Authors:  J J Wang; C Hu; F Lee; M F Shaio; L K Chen
Journal:  Histochemistry       Date:  1992

2.  Identification of a determinant within the human immunodeficiency virus 1 surface envelope glycoprotein critical for productive infection of primary monocytes.

Authors:  P Westervelt; H E Gendelman; L Ratner
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

3.  Expression of nef, vpu, CA and CD4 during the infection of lymphoid and monocytic cell lines with HIV-1.

Authors:  T Schneider; P Hildebrandt; K Rokos; U Schubert; W Rönspeck; C Grund; A Beck; R Blesken; G Kulins; H Oldenburg
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

4.  HIV infection of monocytes inhibits the T-lymphocyte proliferative response to recall antigens, via production of eicosanoids.

Authors:  P Foley; F Kazazi; R Biti; T C Sorrell; A L Cunningham
Journal:  Immunology       Date:  1992-03       Impact factor: 7.397

5.  Phagocytosis reduces HIV-1 production in human monocytes/macrophages infected in vitro.

Authors:  G Piedimonte; M Montroni; G Silvestri; L Silvotti; A Donatini; L Rossi; A F Borghetti; M Magnani
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

6.  HIV-1 infection of in vitro cultured human monocytes: early events and influence of anti HIV-1 antibodies.

Authors:  M Arendrup; S Olofsson; J O Nielsen; J E Hansen
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

7.  DMP 323, a nonpeptide cyclic urea inhibitor of human immunodeficiency virus (HIV) protease, specifically and persistently blocks intracellular processing of HIV gag polyprotein.

Authors:  M M Rayner; B C Cordova; R P Meade; P E Aldrich; P K Jadhav; Y Ru; P Y Lam
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

8.  Targeting antiretroviral nucleoside analogues in phosphorylated form to macrophages: in vitro and in vivo studies.

Authors:  M Magnani; L Rossi; G Brandi; G F Schiavano; M Montroni; G Piedimonte
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

Review 9.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

10.  Dilute passage promotes expression of genetic and phenotypic variants of human immunodeficiency virus type 1 in cell culture.

Authors:  S Sánchez-Palomino; J M Rojas; M A Martínez; E M Fenyö; R Nájera; E Domingo; C López-Galíndez
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.